共 30 条
- [21] A multicenter, open-label, randomized, proof-of-concept phase II clinical trial to assess the efficacy and safety of icatibant n patients infected with SARS-CoV-2 (COVID-19) and admitted to hospital units without invasive mechanical ventilation: study protocol (ICAT-COVID)TRIALS, 2022, 23 (01)Malchair, PierreOtero, AuremaGiol, JordiSolanich, XavierCarnaval, ThiagoFernandez-Nistal, AlonsoSanchez-Gabriel, AnaMontoto, CarmenLleonart, RamonVidela, Sebastian
- [22] A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocolBMC INFECTIOUS DISEASES, 2020, 20 (01)Fragoso-Saavedra, SergioIruegas-Nunez, David A.Quintero-Villegas, AlejandroGarcia-Gonzalez, H. BenjaminNunez, IsaacCarbajal-Morelos, Sergio L.Audelo-Cruz, Belem M.Arias-Martinez, SarahiCaro-Vega, YaninkCalva, Juan JoseLuqueno-Martinez, VeronicaGonzalez-Duarte, AlejandraCrabtree-Ramirez, BrendaCrispin, Jose C.Sierra-Madero, JuanBelaunzaran-Zamudio, Pablo F.Valdes-Ferrer, Sergio I.
- [23] A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocolBMC Infectious Diseases, 20Sergio Fragoso-SaavedraDavid A. Iruegas-NunezAlejandro Quintero-VillegasH. Benjamín García-GonzálezIsaac NuñezSergio L. Carbajal-MorelosBelem M. Audelo-CruzSarahi Arias-MartínezYanink Caro-VegaJuan José CalvaVerónica Luqueño-MartínezAlejandra González-DuarteBrenda Crabtree-RamírezJosé C. CrispínJuan Sierra-MaderoPablo F. Belaunzarán-ZamudioSergio I. Valdés-Ferrer
- [24] Two-week Break in Methotrexate Treatment and COVID-19 Vaccine Response. Results of the Vaccine Response on off Methotrexate (VROOM) Study, an Open Label, Prospective, Two-arm Parallel-group, Multi-center, Superiority, Randomized Controlled TrialARTHRITIS & RHEUMATOLOGY, 2023, 75 : 3331 - 3333Abhishek, AbhishekPeckham, NicholasPade, CorinnaGibbons, JosephCureton, LucyFrancis, AnneBarber, VickiWilliams, JenniferAppelbe, DuncanEldridge, LucyJulier, PatrickAltmann, DanielBluett, JamesBrooks, TimCoates, LauraRombach, InesSemper, AmandaOtter, AshleyValdes, AnaNguyen-Van-Tam, JonathanWilliams, HywelMcKnight, AineBoyton, RosemaryCook, Jonathan
- [25] Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled studyTRIALS, 2021, 22 (01)Haran, John P.Pinero, Jose C.Zheng, YanPalma, Norma AlonzoWingertzahn, Mark
- [26] Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled studyTrials, 22John P. HaranJose C. PineroYan ZhengNorma Alonzo PalmaMark Wingertzahn
- [27] Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)TRIALS, 2020, 21 (01)Duvignaud, AlexandreLhomme, EdouardPistone, ThierryOnaisi, RachaSitta, RemiJournot, ValerieDuc NguyenPeiffer-Smadja, NathanCremer, AntoineBouchet, StephaneDarnaud, ThomasPoitrenaud, DelphinePiroth, LionelBinquet, ChristineMichel, Jean-FrancoisLefevre, BenjaminLebeaux, DavidLebel, JosselinDupouy, JulieRoussillon, CarolineGimbert, AnneWittkop, LindaThiebaut, RodolpheOrne-Gliemann, JoannaJoseph, Jean-PhilippeRichert, LauraAnglaret, XavierMalvy, Denis
- [28] Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial)Trials, 21Alexandre DuvignaudEdouard LhommeThierry PistoneRacha OnaisiRémi SittaValérie JournotDuc NguyenNathan Peiffer-SmadjaAntoine CrémerStéphane BouchetThomas DarnaudDelphine PoitrenaudLionel PirothChristine BinquetJean-François MichelBenjamin LefèvreDavid LebeauxJosselin LebelJulie DupouyCaroline RoussillonAnne GimbertLinda WittkopRodolphe ThiébautJoanna Orne-GliemannJean-Philippe JosephLaura RichertXavier AnglaretDenis Malvy
- [29] A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trialTrials, 21Keisha SmithAmy PaceStephan OrtizShamsah KazaniScott Rottinghaus
- [30] A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trialTRIALS, 2020, 21 (01)Smith, KeishaPace, AmyOrtiz, StephanKazani, ShamsahRottinghaus, Scott